Clinical Epidemiology in Contemporary Patients With Myelofibrosis (ERNEST-3): A European LeukemiaNet (ELN) Observational Study
Status: Recruiting
Location: See all (36) locations...
Study Type: Observational
SUMMARY
Multicenter retrospective and prospective European observational study. At each site, all consecutive patients with a 2016- or 2022 World Health Organization (WHO) confirmed diagnosis of myelofibrosis (MF) established from 01/01/2018 to 31/12/2027 will be enrolled into the study. Yearly follow-up updates will be scheduled until the end of data collection on 31/12/2028 or until the last available patient visit, whichever comes first. At least 1 year of follow-up will be ensured from the last patient enrolled.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:
• Diagnosis of primary myelofibrosis (PMF) or secondary (i.e., post-ET/PV MF) myelofibrosis according to 2016- or 2022-WHO criteria ascertained between 01/01/2018 and 31/12/2027
• Age ≥ 18 years
• Signed informed consent where applicable, in line with current European General Data Protection Regulation (GDPR) directives
Locations
Other Locations
Armenia
Hematology Center after Prof.R.H. Yeolyan
NOT_YET_RECRUITING
Yerevan
Denmark
University of Copenhagen's Roskilde Hospital
NOT_YET_RECRUITING
Copenhagen
France
Clinical Investigation Center of the Saint Louis Hospital
NOT_YET_RECRUITING
Paris
Germany
Internal Medicine C, Hematology, Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald
NOT_YET_RECRUITING
Greifswald
University Hospital Halle Department of Hematology/Oncology
NOT_YET_RECRUITING
Halle
University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden UKRUB, University of Bochum
NOT_YET_RECRUITING
Minden
Israel
Division of Haematology, Sasson University Hospital Assuta Ashdod, Ashdod, Ben-Gurion University of Negev
NOT_YET_RECRUITING
Ashdod
Italy
A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia
RECRUITING
Alessandria
ASST Papa Giovanni XXIII, SC Ematologia
RECRUITING
Bergamo
Policlinico S. Orsola - Malpighi, Unità di Ematologia
NOT_YET_RECRUITING
Bologna
Azienda Ospedaliero - Universitaria Policlinico Vittorio Emanuele - PO Gaspare Rodolico, Dipartimento di ematologia con Trapianto di midollo Osseo
NOT_YET_RECRUITING
Catania
AOU Careggi di Firenze, Divisione di Ematologia
NOT_YET_RECRUITING
Florence
ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia
NOT_YET_RECRUITING
Milan
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Ematologia
NOT_YET_RECRUITING
Milan
Ospedale San Raffaele, Unità Operativa di Ematologia e Trapianto Midollo Osseo
NOT_YET_RECRUITING
Milan
Fondazione IRCCS San Gerardo dei Tintori
NOT_YET_RECRUITING
Monza
Azienda Ospedaliera Universitaria Federico II, Divisione di Ematologia
NOT_YET_RECRUITING
Napoli
Azienda Ospedaliero Universitaria Maggiore della Carità, SCDU Ematologia
RECRUITING
Novara
Azienda Ospedale-Università di Padova, Dipartimento di Medicina
NOT_YET_RECRUITING
Padua
Università degli Studi di Padova - Policlinico Universitario, Clinica Medica 1
NOT_YET_RECRUITING
Padua
Fondazione IRCCS Policlinico San Matteo, Divisione di Ematologia
NOT_YET_RECRUITING
Pavia
Fondazione Policlinico Universitario A. Gemelli - Università Cattolica del Sacro Cuore, UCSC Ematologia
NOT_YET_RECRUITING
Roma
Policlinico Umberto I, Dipartimento Ematologia, Oncologia e Dermatologia
NOT_YET_RECRUITING
Roma
A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette- S.C. Ematologia U
NOT_YET_RECRUITING
Torino
ASST dei Sette Laghi (Ospedale di Circolo e F. Macchi), Divisione U.O. Ematologia
NOT_YET_RECRUITING
Varese
Azienda Ospedaliera Universitaria Integrata - Ospedale Borgo Roma, Unità di Ematologia
NOT_YET_RECRUITING
Verona
Azienda ULSS 8 Berica - Ospedale San Bortolo, Divisione di Ematologia
NOT_YET_RECRUITING
Vicenza
Poland
Department of Hematology, University Hospital, Jagiellonian University Medical College
NOT_YET_RECRUITING
Krakow
Department and Clinic of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University
NOT_YET_RECRUITING
Wroclaw
Republic of Moldova
Institute of Oncology, State University of Medicine and Pharmacy - Department of Oncology, Hematology and Radiotherapy
NOT_YET_RECRUITING
Chisinau
Romania
Department of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute
NOT_YET_RECRUITING
Bucharest
Spain
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - Hospital Clinic
NOT_YET_RECRUITING
Barcelona
Hematology and Hemotherapy Department, 12 de Octubre University Hospital
NOT_YET_RECRUITING
Madrid
Servicio de Hematología - Hospital Clínico Universitario de Valencia
NOT_YET_RECRUITING
Valencia
United Kingdom
School of Medicine, Dentistry and Biomedical Sciences Queen's University Belfast
NOT_YET_RECRUITING
Belfast
Guy's and St. Thomas' NHS Foundation Trust.
NOT_YET_RECRUITING
London
Contact Information
Primary
TIZIANO BARBUI, MD
tbarbui@fondazionefrom.it
0352675134
Backup
FENILI
sperimentazioni@fondazionefrom.it
Time Frame
Start Date: 2024-10-14
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 617
Related Therapeutic Areas
Sponsors
Leads: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Collaborators: GlaxoSmithKline